Universal Health Services, Inc. UHS SPX
Healthcare · Medical Care Facilities · United States
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
READ MORE ›$146.11
-22.94% 1Y
Market & Price
Market Cap
$8.84B
Current Price
$146.11
High / Low (52W)
$243.74 / $146.11
Beta
1.13
Valuation
Stock P/E
6.10
Industry PE
23.65
Forward P/E
5.76
PEG Ratio
1.02
Book Value
$123.31
Price to Book
1.18
P/S
0.50
EV/EBITDA
5.24
Dividend Yield
0.55%
Profitability & Returns
ROCE
17.29%
ROE
21.37%
ROA
8.35%
Profit Margin
8.56%
Op Margin
11.19%
EPS (Latest Qtr)
$5.65
EPS (TTM)
$23.95
Balance Sheet & Liquidity
Debt/Equity
0.67
Quick Ratio
0.88
Current Ratio
1.08
Debt
$5.13B
Total Assets
$15.53B
Current Assets
$3.41B
Working Capital
$168.31M
Ownership
Promoter Holding
4.88%
Chg in Prom Hold
-
FII / Inst Holding
101.64%
Chg in FII Hold
0.01%
Financial Snapshot
Enterprise Value
$13.99B
Total Revenue (TTM)
$17.76B
EBITDA
$2.67B
Free Cash Flow
$650.82M
Operating Cash Flow
$1.91B
Shares Outstanding
53.29M
Gross Margin
44.23%
Payout Ratio
3.34%
Growth (CAGR)
Revenue 5Y
9.03%
Profit 5Y
30.13%
Revenue (YoY)
9.60%
Earnings (YoY)
17.70%
PROS
- Strong return on equity of 21.4%.
- Profit CAGR of 30.1% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 40.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
- RSI at 21 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UHS Universal Health Services, Inc. SPX | 146.11 | 6.10 | $8.84B | 0.55% | 17.29% | 21.37% | 9.03% | 30.13% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | 2.61B | 2.61B | 2.54B | 2.64B | 2.69B | 2.68B | 2.65B | 2.75B | 2.80B | 2.86B | 2.82B | 2.90B | 2.83B | 2.73B | 2.91B | 3.09B | 3.01B | 3.20B | 3.16B | 3.29B | 3.32B | 3.34B | 3.47B | 3.55B | 3.56B | 3.84B | 3.91B | 3.96B | - | 4.10B | 4.28B | 4.50B | 4.49B | 4.50B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 402.88M | 418.79M | 414.58M | 422.76M | 426.54M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.70B | 3.87B | 4.08B | 4.06B | 4.07B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.24B | 3.36B | 3.56B | 3.55B | 3.57B |
| Operating Income | 275.16M | - | 356.32M | 333.29M | 277.57M | - | 353.93M | 330.19M | 257.31M | - | 333.81M | 324.46M | 257.16M | - | 340.44M | 345.56M | 188.93M | - | 236.69M | 358.03M | 349.67M | - | 295.67M | 438.97M | 314.81M | 232.86M | 233.43M | 275.88M | 278.70M | 280.13M | 285.36M | 388.76M | 436.40M | 384.17M | - | 454.82M | 500.27M | 521.69M | 517.23M | 502.86M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 607.98M | 659.85M | 689.32M | 785.99M | 660.51M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 39.21M | 34.46M | 37.37M | 41.21M | 35.97M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 420.43M | 473.38M | 496.89M | 581.44M | 469.12M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 98.80M | 110.77M | 117.78M | 133.60M | 110.44M |
| Net Income | 150.29M | 173.75M | 190.76M | 185.58M | 151.87M | 174.21M | 206.06M | 185.39M | 141.25M | 219.61M | 223.83M | 226.05M | 171.75M | 158.07M | 234.17M | 238.32M | 97.19M | 245.18M | 142.04M | 251.93M | 241.28M | 308.71M | 209.09M | 325.02M | 218.35M | 153.91M | 164.06M | 182.81M | 163.12M | 171.31M | 166.99M | 261.83M | 289.15M | 258.71M | - | 316.68M | 353.22M | 372.96M | 445.94M | 348.68M |
| Diluted EPS | 1.48 | 1.74 | 1.93 | 1.89 | 1.54 | 1.78 | 2.12 | 1.91 | 1.47 | 2.31 | 2.36 | 2.39 | 1.84 | 1.70 | 2.57 | 2.66 | 1.10 | 2.79 | 1.64 | 2.95 | 2.82 | 3.60 | 2.43 | 3.79 | 2.60 | 2.02 | 2.20 | 2.50 | 2.28 | 2.42 | 2.40 | 3.82 | 4.26 | 3.80 | - | 4.80 | 5.43 | 5.86 | 7.06 | 5.65 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 9.77B | 10.41B | 10.77B | 11.38B | 11.56B | 12.64B | 13.40B | 14.28B | 15.83B | 17.36B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.47B | 1.53B | 1.59B | 1.66B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.93B | 12.75B | 14.24B | 15.71B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.92B | 11.57B | 12.56B | 13.71B |
| Operating Income | 410.22M | 520.53M | 505.71M | 897.13M | 942.58M | 1.02B | 1.06B | 1.26B | 1.28B | 1.28B | 1.18B | 1.22B | 1.36B | 1.36B | 1.00B | 1.18B | 1.68B | 1.99B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.58B | 1.72B | 2.27B | 2.74B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 126.89M | 206.67M | 182.51M | 152.26M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 866.26M | 940.43M | 1.50B | 1.97B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 209.28M | 221.12M | 334.83M | 460.96M |
| Net Income | 199.38M | 260.37M | 230.18M | 398.17M | 443.45M | 510.73M | 545.34M | 680.53M | 702.41M | 752.30M | 779.71M | 814.85M | 943.95M | 991.59M | 675.61M | 717.79M | 1.14B | 1.49B |
| Diluted EPS | 1.96 | 2.64 | 2.34 | 4.04 | 4.53 | 5.14 | 5.42 | 6.76 | 7.14 | 7.81 | 8.31 | 9.13 | 10.99 | 11.82 | 9.14 | 10.23 | 16.82 | 23.10 |
Compounded Sales Growth
| 5 Years: | 9.03% |
| 1 Year: | 9.60% |
Compounded Profit Growth
| 5 Years: | 30.13% |
| 1 Year: | 17.70% |
Stock Price Performance
| 1 Year: | -22.94% |
| 6 Months: | -39.95% |
| 3 Months: | -29.04% |
| 1 Month: | -13.01% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 3.96B | 7.53B | 7.67B | 8.20B | 8.31B | 8.95B | 9.62B | 10.32B | 10.76B | 11.27B | 11.67B | 13.48B | - | 13.49B | 13.97B | 14.47B | 15.53B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.54B | 2.81B | 2.82B | 3.41B |
| Cash & Equivalents | 16.35M | 5.46M | 9.18M | 29.47M | 41.23M | 23.47M | 17.24M | 32.07M | 61.23M | 33.75M | 74.42M | 105.22M | 61.27M | 1.22B | - | 102.82M | 119.44M | 125.98M | 137.80M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 218.52M | 216.99M | 220.94M | 232.11M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.02B | 2.24B | 2.18B | 2.60B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.52B | 7.77B | 7.71B | 8.12B |
| Current Liabilities | - | - | 582.82M | 826.30M | 836.93M | 894.06M | 1.06B | 1.18B | 1.10B | 1.32B | 1.85B | 1.45B | 1.56B | 2.48B | - | 1.91B | 2.01B | 2.21B | 3.24B |
| Long Term Debt | - | - | 956.43M | 3.91B | 3.65B | 3.73B | 3.21B | 3.21B | 3.37B | 4.03B | 3.49B | 3.94B | 3.90B | 3.52B | - | 4.73B | 4.79B | 4.46B | 4.00B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.27B | 5.37B | 4.96B | 5.17B |
| Total Equity | - | - | 1.75B | 1.98B | 2.30B | 2.71B | 3.25B | 3.74B | 4.25B | 4.53B | 4.99B | 5.39B | 5.50B | 6.32B | - | 5.92B | 6.15B | 6.67B | 7.28B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 70.63M | 67.18M | 64.98M | 61.06M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 494.19M | 541.26M | 501.34M | 710.68M | 799.23M | 884.24M | 1.04B | 1.07B | 1.33B | 1.25B | 1.27B | 1.44B | 2.36B | - | 996.02M | 1.27B | 2.07B | 1.86B |
| Investing Cash Flow | -295.67M | -390.43M | -2.19B | -285.81M | -789.59M | -383.46M | -832.85M | -912.88M | -1.16B | -684.73M | -747.25M | -688.41M | -802.56M | - | -647.30M | -763.27M | -911.11M | -1.07B |
| Financing Cash Flow | -209.41M | -147.11M | 1.71B | -413.12M | -27.40M | -507.02M | -187.42M | -124.61M | -171.17M | -519.15M | -492.20M | -845.04M | -384.86M | - | -318.40M | -493.94M | -1.14B | -749.73M |
| Capital Expenditure | -354.54M | -379.75M | -239.27M | -285.68M | -363.19M | -358.49M | -391.15M | -379.32M | -519.94M | -557.51M | -664.96M | -634.10M | -731.31M | - | -734.00M | -743.05M | -943.81M | -1.04B |
| Free Cash Flow | 139.65M | 161.51M | 262.07M | 425.00M | 436.04M | 525.75M | 644.73M | 688.94M | 813.90M | 690.08M | 609.78M | 804.37M | 1.63B | - | 262.02M | 524.74M | 1.12B | 824.55M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.33M | 10.58M | 11.12M | 44.05M |
| Share Buybacks | 149.40M | 63.29M | 11.53M | 60.48M | 19.15M | 27.20M | 100.75M | 209.78M | 353.38M | 364.40M | 397.43M | 770.50M | 206.72M | 1.22B | 832.92M | 547.36M | 670.75M | 967.95M |
| Dividends Paid | 16.15M | 16.71M | 19.42M | 19.47M | 58.40M | 19.62M | 29.66M | 39.53M | 38.88M | 38.21M | 37.34M | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 89.0% | 89.3% | 90.0% | 90.4% |
| Operating Margin % | - | - | - | - | - | - | - | - | 13.1% | 12.3% | 10.9% | 10.7% | 11.8% | 10.8% | 7.5% | 8.2% | 10.6% | 11.5% |
| Net Margin % | - | - | - | - | - | - | - | - | 7.2% | 7.2% | 7.2% | 7.2% | 8.2% | 7.8% | 5.0% | 5.0% | 7.2% | 8.6% |
| ROE % | - | 14.9% | 11.6% | 17.3% | 16.3% | 15.7% | 14.6% | 16.0% | 15.5% | 15.1% | 14.5% | 14.8% | 14.9% | - | 11.4% | 11.7% | 17.1% | 20.5% |
| ROCE % | - | 15.4% | 7.5% | 13.1% | 12.9% | 14.0% | 13.7% | 14.8% | 14.2% | 14.4% | 12.0% | 12.0% | 12.4% | - | 8.7% | 9.8% | 13.7% | 16.2% |
Shareholding Pattern
Insiders
4.88%
Institutions
101.64%
Public Float
106.86%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | First Eagle Investment Management, LLC | 8.30% | 4.42M | $646.43M |
| 2 | Blackrock Inc. | 8.15% | 4.35M | $634.86M |
| 3 | Vanguard Capital Management LLC | 6.48% | 3.45M | $504.50M |
| 4 | State Street Corporation | 4.84% | 2.58M | $376.87M |
| 5 | Vanguard Portfolio Management LLC | 4.71% | 2.51M | $366.47M |
| 6 | Geode Capital Management, LLC | 3.66% | 1.95M | $284.60M |
| 7 | Pzena Investment Management LLC | 3.59% | 1.91M | $279.40M |
| 8 | Dimensional Fund Advisors LP | 3.34% | 1.78M | $260.26M |
| 9 | Invesco Ltd. | 2.98% | 1.59M | $232.19M |
| 10 | Goldman Sachs Group Inc | 2.50% | 1.33M | $194.47M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for UHS
No recent headlines available.